image
Regeneron Pharmaceuticals, Inc. REGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
INCOME STATEMENT
14.2 B REVENUE
8.27%
Growth Rates
1Year 8.27%
3Years -4.04%
5Years 12.55%
7Years 13.45%
10Years 17.55%
3.99 B OPERATING INCOME
-1.39%
Growth Rates
1Year -1.39%
3Years -23.59%
5Years 12.55%
7Years 9.76%
10Years 16.88%
4.41 B NET INCOME
11.61%
Growth Rates
1Year 11.61%
3Years -18.25%
5Years 15.84%
7Years 20.47%
10Years 28.91%
EFFICIENCY
Earnings Waterfall Regeneron Pharmaceuticals, Inc.
image
Revenue 14.2 B
Cost Of Revenue 1.97 B
Gross Profit 12.2 B
Operating Expenses 8.24 B
Operating Income 3.99 B
Other Expenses -422 M
Net Income 4.41 B

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990
REVENUE
Revenue 14 202.0 13 117.2 12 172.9 16 071.7 8 497.1 7 863.4 6 710.8 5 872.2 4 860.4 4 103.7 2 819.6 2 104.7 1 378.5 445.8 459.1 379.3 238.5 125.0 63.4 66.2 174.0 57.5 22.0 22.0 59.3 34.5 38.2 33.1 24.1 27.4 23.2 10.6 11.5 7.3 5.0
GROSS PROFIT
Cost Of Revenue 1 970.5 1 815.8 1 560.4 2 437.5 1 119.9 782.2 434.1 397.1 299.7 392.7 205.0 155.4 84.5 4.2 2.1 1.7 0.9 0 8.1 9.6 15.2 6.7 6.5 6.5 15.6 3.6 5.0 2.6 1.1 0 0 0 0 12.8 6.3
Gross Profit 12 231.5 11 301.4 10 612.5 13 634.2 7 377.2 7 081.2 6 276.7 5 475.2 4 560.7 3 711.0 2 614.5 1 949.4 1 294.0 441.6 457.0 377.6 237.5 125.0 55.3 56.6 158.8 50.8 15.5 15.5 43.7 30.9 33.2 30.5 23.0 27.4 23.2 10.6 11.5 (5.5) (1.3)
OPERATING INCOME
Operating Expenses 8 240.8 7 254.3 5 618.5 4 687.4 3 800.6 4 871.4 3 742.3 3 395.6 3 230.0 2 459.1 1 776.1 1 189.4 836.3 646.8 554.5 451.7 327.4 239.5 163.0 (67.8) 153.2 150.8 137.5 101.1 69.0 54.7 45.8 38.0 40.3 35.0 52.4 49.4 29.8 4.1 2.0
Selling, General and Administrative Expenses 2 954.4 2 631.3 2 115.9 1 824.9 1 346.0 1 834.8 1 556.2 1 320.4 1 177.7 838.5 504.8 329.4 210.8 117.3 65.2 52.9 49.3 37.9 25.9 25.5 17.1 14.8 12.5 9.6 8.3 6.4 5.8 5.8 5.9 5.8 8.5 46.3 27.8 3.3 1.7
Research and Development Expenses 5 132.0 4 439.0 3 592.5 2 908.1 2 735.0 3 036.6 2 186.1 2 075.1 2 052.3 1 620.6 1 271.4 859.9 625.6 529.5 489.3 398.8 278.0 201.6 137.1 155.6 136.1 136.0 124.9 91.5 56.3 44.9 37.0 27.8 28.3 23.3 39.7 0 0 0 0
Operating Income 3 990.7 4 047.1 4 738.9 8 946.8 3 576.6 2 209.8 2 534.4 2 079.6 1 330.7 1 251.9 838.4 760.0 457.7 (205.2) (97.5) (74.1) (89.8) (114.5) (107.7) 124.4 5.6 (100.0) (122.0) (85.7) (25.3) (23.8) (12.6) (7.5) (17.3) (7.6) (29.2) (38.8) (18.3) (9.6) (3.3)
PRE-TAX INCOME
Interest Income Expense 55.2 73.0 59.4 57.3 56.9 30.2 28.2 25.1 7.2 14.2 37.4 46.4 45.3 21.3 9.1 2.3 7.8 12.0 0 0 0 0 0 0 4.6 0 0 3.4 14.3 14.7 0 0 0 0 0
Total Other Income 789.2 152.2 119.9 379.0 233.8 219.3 19.1 (1.1) (0.9) (26.8) (62.7) (29.7) (43.3) (17.7) (7.0) 2.2 9.5 8.9 4.5 29.0 36.1 (7.5) (2.4) 9.5 (4.6) 1.0 4.3 6.2 (14.3) 7.6 0 0 0 5.2 0
Pre-Tax Income 4 779.9 4 199.3 4 858.8 9 325.8 3 810.4 2 429.1 2 553.5 2 078.5 1 329.8 1 225.1 775.7 713.4 414.4 (222.9) (104.5) (72.0) (80.4) (93.6) (91.1) 124.4 53.9 (95.5) (112.5) (73.5) (29.9) (22.8) (8.2) (7.5) (17.3) (7.6) 0 0 0 (4.4) 0
NET INCOME
Tax Provision 367.3 245.7 520.4 1 250.5 297.2 313.3 109.1 880.0 434.3 589.0 427.7 289.0 (335.8) (1.1) (2.1) (4.1) 2.4 (29.8) (21.9) 178.8 (84.3) 3.0 (7.0) (21.7) 2.5 (1.7) (8.4) 7.5 29.4 30.6 1.5 1.1 0.8 (10.3) 0
Net Income 4 412.6 3 953.6 4 338.4 8 075.3 3 513.2 2 115.8 2 444.4 1 198.5 895.5 636.1 348.1 424.4 750.3 (221.8) (104.5) (67.8) (82.7) (105.6) (102.3) (95.4) 41.7 (107.5) (124.4) (76.2) (23.2) (23.1) (8.6) (11.6) (32.4) (23.5) (30.7) (39.9) (19.1) (4.5) (3.3)
EPS 40.9 37 40.5 76.4 32.6 19.4 21.3 11.3 8.55 6.17 3.36 4.23 7.92 2.45 1.26 0.85 1.05 1.59 1.77 1.71 0.75 2.13 2.83 1.81 0.66 0.74 0.28 0.4 1.32 1.19 1.62 2.41 1.24 0.29 0.21